ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Clinical and Experimental Dermatology

Clinical and Experimental Dermatology

Volume 18 Issue 5, Pages 425 - 427

Published Online: 27 Apr 2006

Journal compilation © 2010 British Association of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 1390K)  | Related Articles | Citation Tracking

Phototoxic eruptions due to doxycycline—a dose-related phenomenon
A.M. LAYTON 1 W.J. CUNLIFFE 1
  1 Leeds Foundation for Dermatological Research, The General Infirmary at Leeds, UK
Correspondence to  Dr Alison M. Layton, Department of Dermatology, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK.
Copyright 1993 Blackwell Science Ltd

ABSTRACT

AbstractReferences

The tetracycline group of antibiotics still remains the most successful oral treatment for acne. They are relatively free from side-effects apart from the occasional gastrointestinal upset or vaginal candidosis. Rarer side-effects include drug rashes,1 pigmentation with minocycline2 and a light-sensitive eruption with doxycycline.3,4 The incidence of light-sensitive rashes with doxycycline at a dose of 100 mg daily, is in the order of 3%.5 Acne does not always respond to conventional regimens of antibiotics and higher dosages may be required.6 We report a highly significant incidence of light-sensitive eruptions in patients receiving doxycycline at a daily dose of 150 mg or above.


Accepted for publication 25 January 1993

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2230.1993.tb02242.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter